About this event

  • Date and time Wed 1 Sep 2021 from 8:30am to 5:25pm
  • Location Royal Society of Medicine
  • Organised by Surgery, Coloproctology

At this meeting, a multidisciplinary faculty of top experts will provide state of the art lectures on current and emerging treatments for early rectal cancer.

You will learn about less aggressive treatments and stoma avoidance, with a focus on papillon radiotherapy, get updates on clinical trials, hear a patient perspective as part of the main programme, and will be able to discuss individual cases with national and international experts.

This event will educate, inform and influence professionals caring for patients with rectal cancer on the newer options available for the treatment of early tumours, taking into account patient perspectives and the provision of specialist services in the UK and abroad. Author Mark Davis will share his experience as a patient and a multidisciplinary audience will be part of panel discussions on the topics. 

Topics include:

  • To inform the audience about the current status of "Watch and Wait" strategy after (chemo) radiotherapy for early rectal cancer - both in the UK and world wide.
  • To educate multidisciplinary team members including (but not exclusively) surgeons, oncologists, cancer nurses, pathologists and radiologists about the possibility of rectal preservation and stoma avoidance when treating early rectal cancer.
  • To gain the patient perspective on this difficult area of decision making in cancer practice.
  • To understand the influence of the Bowel Screening services on downward stage migration leading to increased diagnosis of earlier rectal cancer, and hence the need for less aggressive treatments.

Can't make it to London for this event? 

You can now live stream this meeting from anywhere. All you need is a good internet connection. Click here to book the live stream.

We would like to thank our sponsors and exhibitors:
Ariane Medical Systems, Clatterbridge Cancer Centre, Clatterbridge Private Clinic and Synmed

Please note that none of the companies listed have had any influence or involvement over the agenda, content or organisation of this meeting.

Join in the conversation online

Follow us on Twitter: @RoySocMed


Standard pricing available until 31 August 2021.


RSM Fellow RSM Associate RSM Trainee RSM Retired Fellow RSM Student
£100.00 £60.00 £60.00 £60.00 £30.00

Non - Member

Consultant / GP Industry Professional Trainee Student AHP / Nurse / Midwife Patient / Carer / Relative Charity
£195.00 £195.00 £100.00 £60.00 £60.00 £45.00 £45.00


View the programme

Registration, tea and coffee
Welcome and introduction

Miss Helen Chave, President, Coloproctology Section, Royal Society Medicine and Professor Jean Pierre Gerard

Session one: Early rectal cancer - options to consider

Chairs: Miss Helen Chave, President and Professor Jean Pierre Gerard

Surgery is the standard of care

Miss Rachel Hargest, Clinical Senior Lecturer in Colorectal Surgery, Cardiff University

When not to operate

Professor Bill Heald, Chairman, Colorectal Programme, Champalimaud Foundation

Contact X-ray brachytherapy - who, how and when?

Professor Arthur Sun Myint, Professor of Oncology, University of Liverpool and Lead Clinician, Clatterbridge Cancer Centre

Watch and wait is an option

Professor Geerard L Beets, Chair, Department of Surgery, The Netherlands Cancer Institute

Panel discussion
Tea and coffee break

Session two: Early rectal cancer - options in practice

Chairs: Miss Rachel Hargest and Professor Simon Gollins, Consultant Oncologist

Is watch and wait safe?

Associate Professor Fraser M Smith, Consultant Colorectal Surgeon, The Royal Liverpool Hospital

TEMS is better for early tumour

Professor Chris Cunningham, Consultant Surgeon

Salvage surgery

Mr Ian Jenkins, Consultant Surgeon, St Mark’s Hospital

Can the NHS afford ‘watch and wait’ programmes in rectal cancer?

Dr Chris Rao, Resident Surgical Officer and Specialist Registrar, St Mark’s Hospital

Dose escalation in radiotherapy

Associate Professor Ane Appelt, Academic Fellow, Leeds Institute of Medical Research, St James's, University of Leeds and Leeds Cancer Centre 

Do patients have a choice?

Mr Mark Davies, Patient and Author

Panel discussion

Trainees Session: Professor Geerard Beets

Session three: Early rectal cancer cases

Chairs: Professor Geerard Beets and Professor Arthur Sun Myint

MDT Case one

Dr Vivek Misra, Consultant Clinical Oncologist, Christie Hospital

MDT Case two

Dr Amandeep Dhadda, Consultant Clinical Oncologist, Queen’s Centre for Oncology

MDT Case three

Dr Raj Sripadam, Consultant Clinical Oncologist, Clatterbridge Cancer Centre

MDT Case four

Mr Mike Davies, Consultant Colorectal Surgeon, University Hospital, Cardiff

MDT Case five

Jeltsje Cnossen, Consultant Oncologist

Session four: Clinical trials in early rectal cancer

Chair: Professor Arthur Sun Myint


Professor Jean Pierre Gerard

The STAR-TREC study: Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer?

Mr Simon P Bach, Consultant Surgeon, Queen Elizabeth Hospital Birmingham


Professor Simon Gollins

Panel discussion
Closing remarks

Professor Arthur Sun Myint and Miss Rachel Hargest


Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Man searching computer

Join the RSM and get unlimited digital learning and e-resources access

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy unlimited digital learning any time you need and access to e-journals, e-books and 6 huge medical databases to support your clinical decision-making and research.

Our e-resources are updated continuously to ensure you receive the cutting edge knowledge you need. 


Become a member